- Home
- INKT vs NMTC Comparison
INKT vs NMTC Comparison
Compare INKT & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- NMTC
- Stock Information
- Founded
- INKT 2017
- NMTC 2009
- Country
- INKT United States
- NMTC United States
- Employees
- INKT N/A
- NMTC N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- NMTC Medical/Dental Instruments
- Sector
- INKT Health Care
- NMTC Health Care
- Exchange
- INKT Nasdaq
- NMTC Nasdaq
- Market Cap
- INKT 31.2M
- NMTC 30.9M
- IPO Year
- INKT 2021
- NMTC N/A
- Fundamental
- Price
- INKT $7.03
- NMTC $0.62
- Analyst Decision
- INKT Strong Buy
- NMTC Strong Buy
- Analyst Count
- INKT 2
- NMTC 1
- Target Price
- INKT $37.50
- NMTC $1.45
- AVG Volume (30 Days)
- INKT 2.8K
- NMTC 358.3K
- Earning Date
- INKT 05-15-2025
- NMTC 05-13-2025
- Dividend Yield
- INKT N/A
- NMTC N/A
- EPS Growth
- INKT N/A
- NMTC N/A
- EPS
- INKT N/A
- NMTC N/A
- Revenue
- INKT N/A
- NMTC $5,749,521.00
- Revenue This Year
- INKT N/A
- NMTC $292.88
- Revenue Next Year
- INKT N/A
- NMTC N/A
- P/E Ratio
- INKT N/A
- NMTC N/A
- Revenue Growth
- INKT N/A
- NMTC 104.21
- 52 Week Low
- INKT $4.56
- NMTC $0.40
- 52 Week High
- INKT $13.79
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- INKT 39.71
- NMTC 44.26
- Support Level
- INKT $7.20
- NMTC $0.60
- Resistance Level
- INKT $7.40
- NMTC $0.66
- Average True Range (ATR)
- INKT 0.39
- NMTC 0.05
- MACD
- INKT -0.02
- NMTC 0.02
- Stochastic Oscillator
- INKT 27.41
- NMTC 40.10
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.